Genus plc logo

Genus plc (GENSF)

Market Closed
8 Dec, 20:00
OTC PINK OTC PINK
$
35. 15
0
0%
$
1.93B Market Cap
43.77 P/E Ratio
0.41% Div Yield
0 Volume
0 Eps
$ 35.15
Previous Close
Day Range
35.15 35.15
Year Range
20.9 35.15
Want to track GENSF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 79 days

Summary

GENSF closed today higher at $35.15, an increase of 0% from yesterday's close, completing a monthly increase of 0% or $0. Over the past 12 months, GENSF stock gained 61.24%.
GENSF pays dividends to its shareholders, with the most recent payment made on Apr 04, 2025. The next estimated payment will be in 8 months ago on Apr 04, 2025 for a total of $0.1331.
The last earnings report, released on Sep 03, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Feb 26, 2026.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).

GENSF Chart

Similar

Rest Ez Inc.
$ -
-
Ping An Healthcare and Technology Company Limited
$ 1.85
0%
Embla Medical Hf Sponsored ADR
$ 5.54
0%
Sesa S.p.A.
$ 121.95
0%
Mesoblast Limited
$ 1.35
0%
British animal genetics firm Genus surges on strong annual profit growth

British animal genetics firm Genus surges on strong annual profit growth

Shares of British animal genetics firm Genus shot up nearly 29% on Thursday, after it reported a 38% surge in annual adjusted pretax profit, on a constant currency basis.

Reuters | 3 months ago
Genus plc (GENSF) Q2 2025 Earnings Call Transcript

Genus plc (GENSF) Q2 2025 Earnings Call Transcript

Genus plc (OTCPK:GENSF) Q2 2025 Earnings Conference Call February 27, 2025 3:30 AM ET Company Participants Jorgen Kokke - CEO Alison Henriksen - CFO Conference Call Participants Charles Hall - Peel Hunt Seb Jantet - Panmure Liberum Limited Sean Conroy - Shore Capital Damian McNeela - Deutsche Bank Christian Glennie - Stifel Alex Jones - Bank of America Edward Sham - Singer Capital Markets Jorgen Kokke Good morning, everyone. Thank you very much for joining us here at Buchanan.

Seekingalpha | 9 months ago

Genus plc (GENSF) FAQ

What is the stock price today?

The current price is $35.15.

On which exchange is it traded?

Genus plc is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is GENSF.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.41%.

What is its market cap?

As of today, the market cap is 1.93B.

When is the next earnings date?

The next earnings report will release on Feb 26, 2026.

Has Genus plc ever had a stock split?

No, there has never been a stock split.

Genus plc Profile

Biotechnology Industry
Healthcare Sector
Mr. Jorgen Kokke CEO
OTC PINK Exchange
GB0002074580 ISIN
GB Country
3,500 Employees
7 Mar 2025 Last Dividend
- Last Split
- IPO Date

Overview

Genus plc is a pioneering animal genetics company that holds a prominent position in the global market with operations spanning North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia. Incorporated in 1994 and headquartered in Basingstoke, United Kingdom, the company has carved a niche for itself through its dedicated efforts in advancing animal breeding and genetics. The business model of Genus plc is structured around three primary segments: Genus PIC, which focuses on porcine genetics; Genus ABS, which specializes in cattle genetics; and Genus Research and Development, which spearheads innovations in animal genetics. Through its comprehensive range of products and unparalleled technical services, Genus plc aims to enhance the productivity and sustainability of the meat and dairy industries.

Products and Services

  • Breeding Pigs and Semen (PIC brand)

    Under the PIC brand, Genus plc offers high-quality breeding pigs and pig semen, tailored to meet the diverse needs of pork production. These genetics solutions are designed to produce pigs with specific characteristics, such as improved growth rates, feed efficiency, and meat quality, helping farmers increase their profitability and meet the growing global demand for pork.

  • Bull Semen and Embryos (ABS, Genus, and Bovec brands)

    The company sells a comprehensive range of bull semen and embryos under the ABS, Genus, and Bovec brands, aiming to enhance the genetics of the dairy and beef herds. These products enable breeders to produce calves with desired traits, such as higher milk production for dairy cows and improved meat quality for beef cattle, contributing to the efficiency and sustainability of dairy and beef production.

  • Technical Services

    In addition to its genetics products, Genus plc offers an extensive array of technical services to farmers. These services are designed to support farmers in maximizing the genetic potential of their herds, improving animal health and productivity, and enhancing overall farm management. This hands-on support ensures that customers can achieve the full benefits of Genus plc's animal genetics technologies.

Contact Information

Address: Matrix House
Phone: 44 1256 347 100